Skip to Content

Clinical Trials Detail

SWOG S0919: A Phase II Study of Idarubicin and Ara-C in Combination with Pravastatin for Relapsed Acute Myelogenous Leukemia

Objective
Not available at this time
IRB Protocol Number
11-0765
Principal Investigator(s)
DAN POLLYEA

Cancer Trials

  • Leukemia/Myelodysplasia
Sponsor(s)
SWOG
Contact
LEIGH WALZER at 720-848-0736
or LEIGH.WALZER@UCDENVER.EDU
Eligibility and Other Participant Information
What To Expect : Not available at this time // Not available at this time